Enveric Biosciences, Inc.
ENVBNASDAQHealthcareBiotechnology
As of Oct 15, 2026 close
- Market cap
- $5.54M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $1.17$13.25
- Volume (live)
- -
- Avg. volume (3M)
- 70.68K
Enveric Biosciences (ENVB) Stock Price & Financial Analysis
Enveric Biosciences Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $1.35 - $1.44 |
|---|---|
| 52-Week High | $13.25 |
| 52-Week Low | $1.17 |
| Open | $1.37 |
| Volume (last close) | 21.20K |
| Average Volume (3M) | 70.68K |
| 50-Day MA | $1.47 |
|---|---|
| 200-Day MA | $2.17 |
| 1-Year Change | −85.30% |
| Market Cap | 5.54M |
|---|---|
| Shares Outstanding | 3.99M |
| Price to Book (P/B) | 0.69 |
| EV/EBITDA | 0.32 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Last Dividend Ex-Date | Apr 23, 2008 |
Source: Market prices and company fundamentals. Data as of Oct 15, 2026. Data sources and methodology
Enveric Biosciences at a Glance
As of the Oct 15, 2026 close, Enveric Biosciences (ENVB) has a market capitalization of $5.54M.
As of its latest reported balance sheet, it holds $8.30M in cash and securities against $0.00 of debt, a net cash position of $8.30M.
Enveric Biosciences does not currently pay a dividend.
The share price is down 85.3% over the past year. At $1.39 (the Oct 15, 2026 close) it sits near the bottom of its 52-week range of $1.17 to $13.25, below its 200-day moving average of $2.17.
Frequently Asked Questions About Enveric Biosciences
What is the current stock price for ENVB?
As of the Oct 15, 2026 close, ENVB stock trades at $1.39. The 52-week range is $1.17–$13.25, with a day range of $1.35–$1.44.
What is the P/E ratio for ENVB?
The P/E ratio (Price-to-Earnings) for ENVB is shown in the Key Statistics section. This valuation metric helps compare Enveric Biosciences, Inc. to industry peers.
Does ENVB pay dividends?
Enveric Biosciences does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for ENVB?
Analyst ratings and recommendations for ENVB are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of ENVB?
As of the Oct 15, 2026 close, Enveric Biosciences's market capitalization is $5.5M, classifying it as a micro-cap company. Enveric Biosciences operates in the Healthcare sector within the Biotechnology industry.